These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant].
    Author: Ceppa F, Kenane N, Chellak S, Bigaillon C, Burnat P.
    Journal: Ann Fr Anesth Reanim; 2005 Apr; 24(4):425-7. PubMed ID: 15826794.
    Abstract:
    Mivacurium and succinylcholine are short-acting neuromuscular blocking drugs. The duration of their action depends on their rapid hydrolysis by plasma cholinesterase or butyrylcholinesterase. More than thirty genetic variants of this enzyme have been described but the atypical variant is the most frequently involved in prolonged apnoea following the administration of these two myorelaxants. We present one case of patient who presented a five hours long apnoea associated with null cholinesterase activity and detection of a butyrylcholinesterase silent variant (Sil-1, 1 for 100,000 persons in population) after sequencing.
    [Abstract] [Full Text] [Related] [New Search]